Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PUPs A-LONG: rFVIIIFc in Previously Untreated Patients with Severe Hemophilia A
NCT02234323Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2015
- Primary completion
- Sep 2019
- Modality
- Fc-Fusion Proteins
- Countries
- 14
01
Overview
A Phase 3 trial of eftrenonacog alfa in hemophilia A, sponsored by Sanofi. Started Jan 2015; status: completed.
02
Drugs
eftrenonacog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02234323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02234323.